Actively Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
Led by Sun Yat-sen University · Updated on 2020-10-22
10000
Participants Needed
1
Research Sites
734 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators are registering all biopsy-proven primary IgA nephropathy (IgAN) patients at recruited hospitals and developing a IgAN database in China. Patients will be follow-up every one year, and both baseline and follow-up information will be entered into the registration system. All-cause and cardiovascular mortality and a composite renal outcome of doubling of serum creatinine and end stage renal failure (ESRD, defined as initiation of dialysis or kidney transplantation) of IgAN patients will be compared using the IgAN database.
CONDITIONS
Official Title
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy-proven primary IgA nephropathy patients
- Age 14 years or older
- Kidney biopsy sample containing at least 8 glomeruli
You will not qualify if you...
- Secondary causes of mesangial IgA deposition such as Henoch-Schonlein purpura nephritis, systemic lupus erythematosus, or liver cirrhosis
- Estimated glomerular filtration rate (eGFR) 15 ml/min/1.73m2 or less at the time of biopsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
X
Xueqing Yu, M.D. & Ph.D
CONTACT
Q
Qiongqiong Yang, M.D. & Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here